A Comparison of Core Depressive Symptom Improvement with Anxiety Symptom Reduction for Depressed Patients Treated with Fluoxetine

10.4103/TPSY.TPSY_20_22

Feng-Chuan Chen；Ta-Chun Lin；Hsin-Yi Lin；Ching-Hua Lin

台灣精神醫學

36卷2期（2022 / 06 / 01）

97 - 99

英文

1. Bech, P(2006).Rating scales in depression: limitations and pitfalls.Dialog Clin Neurosci,8,207-215.
2. Braund, TA,Palmer, DM,Williams, LM(2020).Dimensions of anxiety in major depressive disorder and their use in predicting antidepressant treatment outcome: an iSPOT-D report.Psychol Med,50,1032-1042.
3. Chan, HN,Rush, AJ,Nierenberg, AA(2012).Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report.Int J Neuropsychopharmacol,15,1387-1399.
4. Cleary, P,Guy, W(1977).Factor analysis of the Hamilton depression scale.Drugs Exp Clin Res,1,115-120.
5. Cohen, J(1988).Statistical Power Analysis for the Behavioral Sciences.Hillsdale, New Jersey, USA:L. Erlbaum Associates.
6. Fava, M,Alpert, JE,Carmin, CN(2004).Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.Psychol Med,34,1299-1308.
7. Hamilton, M(1960).A rating scale for depression.J Neurol Neurosurg Psychiatry,23,56-62.
8. Lin, CH,Lane, HY,Chen, CC(2011).Early prediction of fluoxetine response for Han Chinese inpatients with major depressive disorder.J Clin Psychopharmacol,31,187-193.
9. McHorney, CA,Ware, JE, Jr.,Raczek, AE(1993).The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.Med Care,31,247-263.
10. Minium, EW,King, BM,Bear, G(1970).Bear G: Statistical Reasoning in Psychology and Education.Australia:John Wiley & Sons, Limited.
11. Morris, SB,DeShon, RP(2002).Combining effect size estimates in metaanalysis with repeated measures and independent-groups designs.Psychol Methods,7,105-125.
12. Stahl, SM(2013).Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Application.Cambridge, United Kingdom:Cambridge University Press.
13. Thase, ME,Chen, D,Edwards, J(2014).Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder.Int Clin Psychopharmacol,29,351-356.
14. Tourian, KA,Jiang, Q,Ninan, PT(2010).Analysis of the effect of desvenlafaxine on anxiety symptoms associated with major depressive disorder: Pooled data from 9 short-term, double-blind, placebo-controlled trials.CNS Spectr,15,187-193.
15. Weisz, JR,McCarty, CA,Valeri, SM(2006).Effects of psychotherapy for depression in children and adolescents: A meta-analysis.Psychol Bull,132,132-149.